Quadrant Biosciences on Capitol Hill

News Archives - Quadrant Biosciences

Quadrant Biosciences on Capitol Hill

An update from the CEO, Rich Uhlig. I hope everyone is staying safe in these tumultuous times. I wanted to update you on my recent visit to Washington D.C. to engage with key members of Congress and the Executive Branch about our autism saliva test, Clarifi ASD. My colleagues from Quadrant and I had the

Read More...

Autism Saliva Test Aims to Reduce Age of Diagnosis

Increasingly, more research is being published globally supporting the gut-brain connection theory and the important role of epigenetics and the microbiome in relation to autism spectrum disorder (ASD). In 2018, scientists discovered that certain molecules in the saliva, called non-coding RNAs, not only differentiate children with ASD, but appear to correlate with specific autism traits.

Read More...

Bacteria Within A a Child’s Mouth Could Help Identify Autism

New research has recently emerged that “changes in the bacteria within a child’s mouth may provide biomarkers for identifying autism.”[1]  This technology is being developed into a saliva test which will aid clinicians in autism diagnosis. Previous research has established the presence of a disrupted gut-brain signaling in children with autism spectrum disorder (ASD). [2]

Read More...

Quadrant Biosciences Wins New York Technology Award

Quadrant Biosciences Wins New York Technology Award We’re excited to share that our company, Quadrant Biosciences, has been recognized as the New York Technology Business of the Year for our breakthrough epigenetic research! The award, presented by the New York State Small Business Development Center (SBDC),  recognizes the boldest, brightest, and best small companies in

Read More...